Cargando…
Antisense Therapy for Infectious Diseases
Infectious diseases, particularly Tuberculosis (TB) caused by Mycobacterium tuberculosis, pose a significant global health challenge, with 1.6 million reported deaths in 2021, making it the most fatal disease caused by a single infectious agent. The rise of drug-resistant infectious diseases adds to...
Autores principales: | Buthelezi, Lwanda Abonga, Pillay, Shandre, Ntuli, Noxolo Nokukhanya, Gcanga, Lorna, Guler, Reto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453568/ https://www.ncbi.nlm.nih.gov/pubmed/37626929 http://dx.doi.org/10.3390/cells12162119 |
Ejemplares similares
-
Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis
por: Govender, Melissa, et al.
Publicado: (2018) -
Differential Targeting of c-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 Promotes the Intracellular Growth of Mycobacterium tuberculosis in Alternatively IL-4/IL-13 Activated Macrophages
por: Tamgue, Ousman, et al.
Publicado: (2019) -
Antisense Therapy in Neurology
por: Lee, Joshua J.A., et al.
Publicado: (2013) -
Targeting Batf2 for infectious diseases and cancer
por: Guler, Reto, et al.
Publicado: (2015) -
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
por: Sardone, Valentina, et al.
Publicado: (2017)